Table 2 Baseline characteristics
Characteristic | Group 1 (Class I) | Group 2 (Class II) |
|---|---|---|
Age (years) Mean ± SD | 30.51 ± 10.03 | 32.62 ± 11.95 |
Total treatment time (years) Mean ± SD | 1.29 ± 0.52 | 2.35 ± 0.65 |
Duration MTAD (months) Mean ± SD | 10.20 ± 5.10 | |
Gender n (%) | ||
Female | 33 (82.5%) | 33 (82.5%) |
Male | 7 (17.5%) | 7 (17.5%) |
Localization Class II n (%) | ||
Bilateral | 32 (80.0%) | |
Unilateral | 8 (20.0%) |